Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Acute intestinal ischemic injury (i3) is a life-threatening condition with disastrous prognosis, which is currently difficult to diagnose at the early stages of the disease; a rapid diagnosis is mandatory to avoid irreversible ischemia, extensive bowel resection, sepsis and death. The overlapping protein expression of liver and gut related to the complex physiopathology of the disease, the heterogeneity of the disease and its relative rarity could explain the lack of a useful early biochemical marker of i3. Apart from non-specific biological markers of thrombosis, hypoxia inflammation, and infection, several more specific biomarkers in relation with the gut barrier dysfunction, the villi injury and the enterocyte mass have been used in the diagnosis of acute i3. It includes particularly D-lactate, intestinal fatty acid-binding protein (FABP) and citrulline. Herein, we will discuss leading publications concerning these historical markers that point out the main limitations reagrding their use in routine clinical practice. We will also introduce the first and limited results arising from omic studies, underlying the remaining effort that needs to be done in the field of acute i3 biological diagnosis, which remains a challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, no specific clinical or biological signs have proven to be sufficiently sensitive or specific to suggest the diagnosis in the emergency setting [1, 9, 13, 26].”
From Improving clinical suspicion of acute mesenteric ischemia among patients with acute abdomen: A cross-sectional study from an intestinal stroke center (2023) · cites this paper as [13]
In the citing paper
“Moreover, no biomarker is currently validated or available [12, 13].”
From Improving clinical suspicion of acute mesenteric ischemia among patients with acute abdomen: A cross-sectional study from an intestinal stroke center (2023) · cites this paper as [13]
Citations
Cites
Chiu, C.-J. (1970) · Archives of Surgery · doi:10.1001/archsurg.1970.01340280030009 · Cited by 1,800
Multiple Organ Failure Pathophysiology and Potential Future Therapy
DEITCH, E. A. (1992) · Annals of Surgery · doi:10.1097/00000658-199208000-00002 · Cited by 1,380
Kumar, S., Sarr, M. G., & Kamath, P. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010076 · Cited by 649
Clair, D. G., & Beach, J. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1503884 · Cited by 589 · cited 1×
“However, at this stage, the clinical presentation is dominated by acute non-specific abdominal pain without any other discriminating clinical or biological characteristics [3].”
BackgroundCitrulline as a biomarker of intestinal failure due to enterocyte mass reduction
Crenn, P., Messing, B., & Cynober, L. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.02.005 · Cited by 586 · cited 2×
“Moreover, post prandial samples are associated with a 10%–20% decrease in blood concentration [72].”
BackgroundSystematic review of survival after acute mesenteric ischaemia according to disease aetiology
Schoots, I. G., Koffeman, G. I., Legemate, D. A., Levi, M., & van Gulik, T. M. (2004) · Journal of British Surgery · doi:10.1002/bjs.4459 · Cited by 502 · cited 1×
“The systemic consequences of bowel ischemia and necrosis are lethal in most patients in the absence of curative treatment including revascularization [25, 26].”
BackgroundCrenn, P., Coudray–Lucas, C., Thuillier, F., Cynober, L., & Messing, B. (2000) · Gastroenterology · doi:10.1053/gast.2000.20227 · Cited by 498 · cited 1×
“Its plasmatic concentration depends on gut synthesis and renal elimination, decreasing in short bowel conditions and thus known as a functional marker of enterocyte mass, correlated with remnant small bowel length and home parenteral nutrition dependence [70].”
BackgroundContributions of ischemia and reperfusion to mucosal lesion formation
Parks, D. A., & Granger, D. N. (1986) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1986.250.6.g749 · Cited by 472 · cited 1×
“Subsequent mucosal/submucosal ischemia evolves into transmural ischemia, often acute, followed by intestinal necrosis and death without treatment [5].”
BackgroundOckner, R. K., & Manning, J. A. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107768 · Cited by 471 · cited 1×
“In physiological conditions, I-FABP is low in peripheral circulation and is cleared via the urine [62, 63].”
BackgroundINTESTINAL CROSSTALK: A NEW PARADIGM FOR UNDERSTANDING THE GUT AS THE "MOTOR" OF CRITICAL ILLNESS
Clark, J. A., & Coopersmith, C. M. (2007) · Shock · doi:10.1097/shk.0b013e31805569df · Cited by 444
Cited by
Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery.
Bala, M., Catena, F., Kashuk, J., De Simone, B., Gomes, C. A., Weber, D., Sartelli, M., Coccolini, F., Kluger, Y., Abu-Zidan, F. M., et al. (2022) · World Journal of Emergency Surgery · doi:10.1186/s13017-022-00443-x · Cited by 380
Biochemical markers of acute intestinal ischemia: Possibilities and limitations
Montagnana, M., Danese, E., & Lippi, G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.22 · Cited by 108
Peng, J., Leng, J., Tian, H., Yang, T., Fang, Y., Feng, Q., Zhao, Y., & Hu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01399 · Cited by 82
“Coupled with our previous founds that dysbiosis of gut microbiota existed in NAFLD FIGURE 4 | Effects of GC combination on LPS and D-lactate in plasma and tight junction protein expression in colon tissue in NAFLD induced by HFD. (A) LPS and D-lactate in plasma.”
BackgroundInfluentialAccuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
Nuzzo, A., Guedj, K., Curac, S., Hercend, C., Bendavid, C., Gault, N., Tran-Dinh, A., Ronot, M., Nicoletti, A., Bouhnik, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98012-w · Cited by 67
Self-citationLinsalata, M., Riezzo, G., Clemente, C., D’Attoma, B., & Russo, F. (2020) · Disease Markers · doi:10.1155/2020/2886268 · Cited by 56
“It is located in mature enterocytes on the tip of the intestinal villi, which is the anatomical region that is first affected by mucosal damage [15, 16].”
Background
Metadata
- Authors
- Peoc’h, K., Nuzzo, A., Guedj, K., Paugam, C., & Corcos, O.
- Affiliations
- Inserm (FR)
- Hôpital Beaujon (FR)
- SURVI, Hôpital Beaujon, APHP, HUPNVS, DHU Unity , Clichy , France
- Anesthésie Réanimation, Hôpital Beaujon , Université Paris Diderot, UFR de Médecine Xavier Bichat and APHP, HUPNVS , Clichy , France
- Corresponding author
- Peoc’h, Katell
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-08-25
- Volume
- 56
- Issue
- 3
- Pages
- 373-385
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2748404087
- Cited by
- 86
- References
- 84
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 12 · 2023: 11 · 2022: 11 · 2021: 15 · 2020: 7 · 2019: 5 · 2018: 6 · 2017: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- biomarkers, early diagnosis, D-lactate, intestinal fatty acid binding protein, citrulline, intestinal barrier dysfunction, enterocyte mass, ischemic colitis
- MeSH terms
- Acute Disease, Citrulline, Humans, Intestines, Biomarkers, Reperfusion Injury, Lactic Acid, Fatty Acid-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. https://app.cochat.ai/papers/10.1515/cclm-2017-0291
- The paper
- Peoc’h, K., Nuzzo, A., Guedj, K., Paugam, C., & Corcos, O. (2018). Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2017-0291
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.